Applicant, as named in the Orange Book

Tersera

Next listed expiry: Varubi on 9 Oct 2029. 2 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Varubi rolapitant hydrochloride	rolapitant hydrochloride	206500	9 Oct 2029	patent
Xermelo telotristat etiprate	telotristat etiprate	208794	28 Feb 2031	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zoladex goserelin acetate	goserelin acetate	019726	open now	no listed protection
Zoladex goserelin acetate	goserelin acetate	020578	open now	no listed protection